Seguir
Enrico Longato
Enrico Longato
Department of Information Engineering, University of Padova
E-mail confirmado em dei.unipd.it
Título
Citado por
Citado por
Ano
Prevalence and impact of diabetes among people infected with SARS-CoV-2
GP Fadini, ML Morieri, E Longato, A Avogaro
Journal of endocrinological investigation 43, 867-869, 2020
6282020
A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models
E Longato, M Vettoretti, B Di Camillo
Journal of biomedical informatics 108, 103496, 2020
1252020
Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: a case‐control study
GP Fadini, ML Morieri, E Longato, BM Bonora, S Pinelli, E Selmin, ...
Diabetes, Obesity and Metabolism 22 (10), 1946-1950, 2020
1082020
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life
E Longato, B Di Camillo, G Sparacino, L Gubian, A Avogaro, GP Fadini
BMJ Open Diabetes Research and Care 8 (1), e001451, 2020
662020
Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy)
E Longato, B Di Camillo, G Sparacino, C Saccavini, A Avogaro, GP Fadini
Nutrition, Metabolism and Cardiovascular Diseases 30 (1), 84-91, 2020
532020
A deep learning approach to predict diabetes’ cardiovascular complications from administrative claims
E Longato, GP Fadini, G Sparacino, A Avogaro, L Tramontan, ...
ieee journal of biomedical and health informatics 25 (9), 3608-3617, 2021
352021
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice
E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ...
Cardiovascular diabetology 19, 1-12, 2020
312020
Simple linear support vector machine classifier can distinguish impaired glucose tolerance versus type 2 diabetes using a reduced set of CGM-based glycemic variability indices
E Longato, G Acciaroli, A Facchinetti, A Maran, G Sparacino
Journal of diabetes science and technology 14 (2), 297-302, 2020
192020
Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data
E Longato, G Acciaroli, A Facchinetti, L Hakaste, T Tuomi, A Maran, ...
Computers in biology and medicine 96, 141-146, 2018
182018
Overview of iDPP@ CLEF 2022: the intelligent disease progression prediction challenge
A Guazzo, I Trescato, E Longato, E Hazizaj, D Dosso, G Faggioli, ...
CEUR WORKSHOP PROCEEDINGS 3180, 1130-1210, 2022
172022
Overview of iDPP@ CLEF 2023: the intelligent disease progression prediction challenge
G Faggioli, A Guazzo, S Marchesin, L Menotti, I Trescato, A Helena, ...
CEUR WORKSHOP PROCEEDINGS 3497, 1123-1164, 2023
152023
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes
E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ...
European journal of preventive cardiology 28 (1), 22-29, 2021
142021
Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: retrospective cohort study and meta‐analysis
ML Morieri, BM Bonora, E Longato, B Di Camilo, G Sparacino, ...
Diabetes, Obesity and Metabolism 22 (10), 1925-1934, 2020
132020
HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability
B Di Camillo, L Hakaste, F Sambo, R Gabriel, J Kravic, B Isomaa, ...
European journal of endocrinology 178 (4), 331-341, 2018
132018
Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin
E Longato, M Garrido, D Saccardo, C Montesinos Guevara, AR Mani, ...
PloS one 12 (6), e0180315, 2017
122017
Intelligent disease progression prediction: overview of iDPP@ CLEF 2022
A Guazzo, I Trescato, E Longato, E Hazizaj, D Dosso, G Faggioli, ...
International Conference of the Cross-Language Evaluation Forum for European …, 2022
102022
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study
ML Morieri, E Longato, M Mazzucato, B Di Camillo, A Cocchiglia, ...
Cardiovascular Diabetology 18, 1-9, 2019
102019
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study
E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ...
Cardiovascular Diabetology 20, 1-12, 2021
72021
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studies
E Longato, BM Bonora, B Di Camillo, G Sparacino, L Tramontan, ...
Diabetes Research and Clinical Practice 179, 109024, 2021
72021
Prediction of cardiovascular complications in diabetes from pharmacy administrative claims
E Longato, GP Fadini, G Sparacino, L Gubian, B Di Camillo
2020 IEEE 20th Mediterranean Electrotechnical Conference (MELECON), 315-320, 2020
72020
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20